Skip to main content
logo

Cheng Li

Stock Analyst at Oppenheimer

(0.89)
# 3,998
Out of 5,113 analysts
3
Total ratings
33.33%
Success rate
-1.58%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology

Stocks Rated by Cheng Li

Wave Life Sciences
Dec 16, 2025
Maintains: Outperform
Price Target: $24 → $32
Current: $12.73
Upside: +151.37%
Vaxart
Aug 15, 2024
Initiates: Outperform
Price Target: $4
Current: $0.64
Upside: +521.12%